PARIS, October 2 /PRNewswire/ -- Valeo's driving assistance systems act as virtual co-pilots, assisting the driver's own eyes. Based on its full range of radar, ultrasonic and camera surveillance systems, Valeo offers solutions that monitor the vehicle's environment and provide the driver with 360degrees vision thus enhancing safety and driving comfort during low-speed maneuvers.

REHOVOT, Israel, October 2 /PRNewswire/ --

- Expanded Availability of DurusWhite Follows High Acceptance by Objets Users

Objet Geometries Ltd. (http://www.objet.com), the innovation leader in 3-D printing, today announced that Durus(TM) FullCure(R) line of photopolymer materials has been expanded to support the Eden250(TM) and Eden260(TM) office machines and is now available in 2kg cartridges.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080514/305187 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20080715/313718-b )

LONDON, October 2 /PRNewswire/ --

- New Roaming Partnerships Announced

FREEDOM4 (http://freedom4wifi.com) has launched a new service to enable customers to get the best possible broadband wireless connection whilst on the move. The combined 3G and WiFi software along with the plug-in dongle selects the highest quality connectivity at any given location to provide users with the ultimate flexible wireless service.

The new service, Mobile Broadband 1000 (http://www.freedom4wifi.com/shop.php), provides a range of value-added services including a WiFi hotspot locator from Satellite Navigation Systems, and a text service to find the nearest wireless access point to your current position.

ROSH-HA'AYIN, Israel, October 2 /PRNewswire/ -- Kornit Digital, a leading-edge company that develops, manufactures and markets high-speed industrial digital inkjet printers, superior pigmented ink and unique chemistry solutions for the garment & apparel decorating industry, is proud to announce the launch of the new Kornit QuickP RIP Software for enhanced workflow and production.

BEERSE, Belgium, October 2 /PRNewswire/ -- Today, Janssen-Cilag are celebrating their 50 year commitment to researching and developing innovative medicines to help improve the lives of people with mental health problems. Back in 1958, the late Dr. Paul Janssen developed one of the first anti-psychotic drugs, which proved to be a real breakthrough in the treatment of schizophrenia and hailed the onset of a new era for patients being treated outside of institutions. Over the past 50 years, Janssen-Cilag have developed several new compounds in the field of mental health, constantly raising the bar in treatment expectations for many patients.

STOCKHOLM, October 2 /PRNewswire/ -- Athera Biotechnologies AB and Dyax Corp. (NASDAQ:DYAX) announced today that they have entered into a collaboration to discover and to develop therapeutic products for the prevention or treatment of cardiovascular inflammatory diseases.

The collaboration follows the recent publication of work by Athera scientific founders, Professors Frostegard and de Faire of the Karolinska Institutet. The research links naturally occurring antibodies against phosphorylcholine (PC) to atherosclerosis, and correlates low antibody levels with an increased risk of developing cardiovascular disease. Atherosclerosis is a chronic inflammatory disease in which the walls of the blood vessels are thickened and become less elastic.

LONDON, October 2 /PRNewswire/ --

- The Maritime Division of Real-Time Vehicle Tracking Specialists Cybit Provide a Full Boat and Buoy Tracking and Timing System for the Vigo Grand Prix of the Sea

BlueFinger Ltd (http://www.bluefinger.com), the maritime division of Cybit Holdings Plc - one of Europe's leading real-time vehicle tracking and offshore telematics companies, was awarded a contract for the Powerboat P1 (http://www.powerboatp1.com) championship during the Vigo Grand Prix of the Sea in Spain to provide an innovative race management and timing solution developed from BlueFinger's Saffire-online vessel tracking solutions.

BRUSSELS, October 2 /PRNewswire/ --

- Twelve Winners From Across Europe Awarded Research Funding

- With Photo

Twelve winners from across Europe have today been announced as the recipients of the 2008 EURO-NOTES Foundation Research Grant totalling EUR357,000, which will be divided amongst all of the winners. The aim of the unrestricted grant is to support fundamental research on emerging Natural Orifice Translumenal Endoscopic Surgery (NOTES) and has been made possible by support from Ethicon Endo-Surgery.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081002/323296 )

NEWBURY, England, October 2 /PRNewswire/ --

- New Drug Xarelto(R) (Rivaroxaban), Which has Been Shown to be Significantly More Effective Than Current Standard, Gets UK Licence

A new drug launched today could help in the fight against what experts and campaigners are calling a 'major patient safety issue'(1) - the prevention of hospital-acquired DVT (deep vein thrombosis). Xarelto, a once-daily tablet which has been shown to be significantly more effective than the existing standard treatment, injectable enoxaparin(2)-(3), could help prevent unnecessary deaths from hospital-acquired DVT in patients undergoing elective hip or knee replacement surgery - one of the groups at highest risk(1).

PARIS, October 2 /PRNewswire/ --

- Picture is available via EPA (European Pressphoto Agency) and can be downloaded free of charge at: http://www.presseportal.de/pm/59428/general_motors_gm_europe/?keygroup=bild

General Motors Europe President Carl-Peter Forster appealed to European politicians to help restore consumer confidence in the markets. He also called for clear, European-wide environmental laws at a GM press conference at the Paris Motor Show.

"In view of the gloomy market developments in Spain, Great Britain and Germany there must be an end to the uncertainty for consumers. The high oil and energy prices are hitting the middle class to the bone," he said.